Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)

SHA:600285 Revenue

Henan Lingrui Pharmaceutical had revenue of 991.98M CNY in the quarter ending September 30, 2026, with 5.29% growth. This brings the company's total for the last twelve months to 3.95B, up 4.46% year-over-year. In the year 2025, Henan Lingrui Pharmaceutical had annual revenue of 3.85B with 10.07% growth. That makes Henan Lingrui Pharmaceutical the 10,334th largest company in the world by revenue and 1,681st in China.

• Revenue (ttm): 3.95B
• Revenue Growth: +4.46%
• P/S Ratio: 3.43
• Revenue / Employee: 1.42M
• Employees: 2,789
• Market Cap: 13.54B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical and Healthcare Division 3.85B 99.2%
• Others 29.92M 0.8%

Fiscal year ended Dec 31, 2025 See the full SHA:600285 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.85B	352.56M	10.07%
Dec 31, 2024	3.50B	189.36M	5.72%
Dec 31, 2023	3.31B	309.61M	10.31%
Dec 31, 2022	3.00B	308.35M	11.45%
Dec 31, 2021	2.69B	361.93M	15.52%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error